This mysterious autoimmune disease presents with over 100 different symptoms, making diagnosis incredibly challenging for ...

An extension trial revealed that long-term anifrolumab treatment improved health status and health-related quality of life in ...

Lupus Awareness Month shines a spotlight on a disease that affects millions worldwide yet remains widely misunderstood. Lupus ...

Lupus is a rare autoimmune disease characterized by chronic inflammation. It presents in four main forms: systemic lupus ...

Patients who develop LN within 1 to 5 years after SLE onset may face poorer renal outcomes compared with those who develop the disease earlier.

It started with a fever, then every part of my body was swelling – my hands, face, feet. It was very distressing. I would ...

While cohort A met the primary endpoint among other endpoints in the Phase II trial, cohort B failed to meet its primary ...

Anti-TFAM antibodies are detected in about one third of patients with systemic lupus erythematosus and are associated with a ...

Since joining the Lupus Research Alliance (LRA) in 2015, Albert T. Roy has risen to the role of president and CEO. During ...

To better compare belimumab’s efficacy with results from phase 3 trials of obinutuzumab, investigators conducted a post hoc analysis of patients with active proliferative lupus nephritis in the MMF ...

Of the participants completing the study, 18% were classified as having SLE, 46% as incomplete SLE, and 36% as not showing any indication of SLE. These results demonstrate the potential for digital ...